Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LIFILEUCEL for Malignant melanoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 27 adverse event reports in the FDA FAERS database where LIFILEUCEL was used for Malignant melanoma.

Most Reported Side Effects for LIFILEUCEL

Side Effect Reports % Deaths Hosp.
Pyrexia 30 15.2% 7 16
Hypotension 25 12.6% 11 19
Cytokine release syndrome 18 9.1% 2 14
Chills 16 8.1% 4 8
Hypoxia 16 8.1% 4 13
Acute kidney injury 15 7.6% 7 13
Atrial fibrillation 14 7.1% 6 11
Malaise 14 7.1% 5 4
Pancytopenia 14 7.1% 5 12
Multiple organ dysfunction syndrome 12 6.1% 9 11
Thrombocytopenia 12 6.1% 7 10
Nausea 11 5.6% 4 6
Acute respiratory failure 10 5.1% 3 9
Death 10 5.1% 10 5
Respiratory failure 10 5.1% 4 6

Other Indications for LIFILEUCEL

Metastatic malignant melanoma (53) Product used for unknown indication (49) Neoplasm (8) Non-small cell lung cancer (7) Cervix carcinoma (6)

Other Drugs Used for Malignant melanoma

NIVOLUMAB (10,599) IPILIMUMAB (8,903) DABRAFENIB (5,277) TRAMETINIB DIMETHYL SULFOXIDE (3,841) PEMBROLIZUMAB (3,261) BINIMETINIB (2,613) ENCORAFENIB (2,591) VEMURAFENIB (2,548) TRAMETINIB (1,448) COBIMETINIB (1,324)

Related Pages

LIFILEUCEL Full Profile All Malignant melanoma Drugs LIFILEUCEL Demographics LIFILEUCEL Timeline